Skip to main content
BenevolentAI logo

BenevolentAI

Updated Mar 24, 2026

Everything you need to know about BenevolentAI — from their $292M in funding to who's backing them.

🇬🇧United KingdomAcquiredAI Healthcare

Out of 100

🇬🇧

HQ

United Kingdom

🗓

Founded

2013

💰

Raised

$292M

🏷️

Stage

Acquired

👥

Team

100-500

BenevolentAI applies machine learning to drug discovery, using knowledge graph technology and predictive AI models to identify novel drug candidates and repurpose existing compounds for new therapeutic applications. The London-based company has built a proprietary biomedical knowledge graph containing billions of data points extracted from scientific literature, clinical trial data, and genomic

Is this your company? Claim it →

Key Facts

  • BenevolentAI has raised a total of $292M in disclosed funding across 5 funding rounds.
  • BenevolentAI was founded in 2013 by Joanna Shields and is headquartered in United Kingdom.
  • BenevolentAI employs approximately 100-500 people.
  • BenevolentAI operates in the AI Healthcare category and is currently at the Acquired stage.
  • BenevolentAI has an Awaira Score of 62/100, ranking it among the tracked AI companies on Awaira.
  • BenevolentAI's most recent funding round was a Series D of $116.8M closed in October 2018, led by Temasek Holdings.

Source: Awaira · Updated Mar 24, 2026

N/A

Post-money

$292M

All rounds

62/100

2013

100-500 employees

Strengths

Strong Awaira Score of 62/100

Large team of 100-500+ employees

Established market presence (founded 2013)

Considerations

!

Valuation not publicly disclosed

Analysis based on publicly available data. Not investment advice.

5

Total Rounds

$58.4M

Avg Round Size

5.4yr

Funding Span

BenevolentAI raised 5 rounds over 5.4 years, averaging $58.4M per round — a pace of roughly one round every 13 months.

⚠️ ESTIMATE
💵Est. Annual Revenue
$20M–$100M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does BenevolentAI stack up against competitors?

MetricBenevolentAIButterfly NetworkTempusAlan
Awaira Score62/10085/10084/10083/100
Total Raised$292M$370M$1.05B$750M
ValuationN/A$957M$8.1B$5.83B
StageAcquiredPublicPublicSeries D
Founded2013201120152016
Employees100-500500-10002500500-1000
Country🇬🇧🇺🇸🇺🇸🇫🇷
J

Joanna Shields

Former CEO

View founder profile →
StageAcquired
Employees100-500
Country🇬🇧 United Kingdom
Connect
Temasek HoldingsWoodford Investment ManagementKen Griffin
Inactive
5 rounds
Series DLatest

Led by Temasek Holdings

$116.8M

Oct 2018

Series C

Led by Temasek Holdings

$90.52M

Jun 2017

Series B

Led by Woodford Investment Management

$52.56M

Feb 2016

Series A

Led by Woodford Investment Management

$23.36M

Oct 2014

Seed

Led by Ken Griffin

$8.76M

Jun 2013

Frequently Asked Questions

What is BenevolentAI's valuation?
No public valuation has been disclosed yet. The company operates in the AI Healthcare space and may reveal this in a future round.
Who invested in BenevolentAI?
Known backers include Temasek Holdings, Woodford Investment Management, Ken Griffin. These investors have supported the company through various funding rounds.
When did BenevolentAI last raise funding?
Last raise: a Series D of $116.8M in October 2018. The round was led by Temasek Holdings.
How many employees does BenevolentAI have?
The team is roughly 100-500 people, headquartered in United Kingdom.
What does BenevolentAI do?
BenevolentAI applies machine learning to drug discovery, using knowledge graph technology and predictive AI models to identify novel drug candidates and repurpose existing compounds for new therapeutic applications. The London-based company has built a proprietary biomedical knowledge graph containing billions of data points extracted from scientific literature, clinical trial data, and genomic databases, which feeds its target identification and molecule generation pipelines.
Who founded BenevolentAI?
Joanna Shields founded the company in 2013 in United Kingdom. Joanna Shields serves as Former CEO.
Is BenevolentAI profitable?
Profitability details aren't publicly disclosed. The company has raised $292M in total funding and is currently at the Acquired stage.
Where is BenevolentAI headquartered?
Headquarters are in United Kingdom 🇬🇧. The company operates in the AI Healthcare sector and was established in 2013.
⚔️

Compare BenevolentAI

See how BenevolentAI stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →